AbCellera Biologics Ownership & Insider Activity

AbCellera Biologics (ABCL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.7% of shares outstanding. Institutional investors hold 8.6%. Over the past 90 days, insiders made 4 purchases worth $1.5M.

Shares Outstanding

324.047M

Shares Float

254.306M

Insider Shares Owned

5.217M

Insider % Owned

1.7%

Institutional Shares Held

28.007M

Institutional % Held

8.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$1.5M total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$1.5M

AbCellera Biologics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 24, 2026	Michael Hayden	DIRECTOR	BUY	53.613K	$10.64	$570K
Aug 18, 2026	John Montalbano	DIRECTOR	BUY	10.000K	$11.03	$110K
Aug 14, 2026	Andrew Booth	CHIEF FINANCIAL OFFICER	BUY	37.200K	$10.32	$384K
Aug 12, 2026	Michael Hayden	DIRECTOR	BUY	46.387K	$10.37	$481K
May 14, 2026	John Montalbano	DIRECTOR	BUY	20.000K	$4.77	$95K